Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$26.24 - $39.63 $3.76 Million - $5.68 Million
143,300 Added 135.32%
249,200 $9.8 Million
Q1 2023

May 15, 2023

BUY
$18.67 - $24.56 $1.98 Million - $2.6 Million
105,900 New
105,900 $2.58 Million
Q3 2022

Nov 14, 2022

BUY
$9.4 - $18.59 $376,000 - $743,600
40,000 New
40,000 $718,000
Q1 2022

May 16, 2022

BUY
$12.15 - $16.83 $558,900 - $774,179
46,000 Added 460.0%
56,000 $942,000
Q3 2021

Nov 15, 2021

BUY
$7.07 - $17.5 $70,700 - $175,000
10,000 New
10,000 $162,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.